During the surgical strike in 2016 along the Line of Control, bleeding control product Axiostat was used to sustain the life of an Indian soldier until a helicopter transferred him to a medical facility, claims Leo Mavely, founder and chief executive officer of Axio Biosolutions.
Founded in 2008, Bengaluru-based Axiostat is a clinically-endorsed bandage to stop excessive blood loss. It recently raised $7.4-million in Series-B funding from Ratan Tata-backed UC-RNT Fund and existing investors Accel Partners and IDG. Last week, it received clearance from the Food and Drug Administration (FDA) to market its products in the US. The start-up also